SearcharxivSearch

arXiv subjects

Priyesh Bipath

Publications and source records attributed to Priyesh Bipath.

2 recordsLinked to original sources

Quantifying antiproliferative effects of quinolinic acid on melanoma, macrophage and keratinocyte cells using a parametric cell-viability model

This paper presents a robust mathematical framework for quantifying antiproliferative effects from noisy in vitro cell viability experiments. The methodology is demonstrated using crystal violet assay measurements of quinolinic acid-induced growth inhibition in B16-F10 murine melanoma, RAW264.7 macrophage, and HaCaT keratinocyte cells through parametric cell viability models. Experimental data exhibited substantial variability and violated the independence assumptions underlying classical inferential statistics. To address these challenges, the proposed framework combines minimal statistical analysis, comprising model-free confidence intervals and pooled within-replicate variability, with deterministic approximation based on least-squares fitting to experimental means and leave-one-replicate-out cross-validation. While all three cell types were described by a common mechanistic framework, each required a distinct parameterisation to capture its characteristic response to quinolinic acid. The resulting one- and two-parameter models accurately described dose- and time-dependent inhibition, with predictive errors close to the intrinsic experimental variability. The models also yielded explicit expressions for time-dependent IC50 values, enabling reliable prediction of inhibitor concentrations required to achieve specified levels of growth inhibition. The proposed framework provides a practical and robust approach for analysing noisy preclinical cell viability data and can be readily extended to other antiproliferative agents and experimental systems.

q-bio.QM

Quantifying assays: A Modeling tale of variability in cancer therapeutics assessed on cancer cells

Inhibiting a signalling pathway concerns controlling the cellular processes of a cancer cell's viability, cell division, and death. Assay protocols created to see if the molecular structures of the drugs being tested have the desired inhibition qualities often show great variability across experiments, and it is imperative to diminish the effects of such variability while inferences are drawn. In this paper we propose the study of experimental data through the lenses of a mathematical model depicting the inhibition mechanism and the activation-inhibition dynamics. The method is exemplified through assay data obtained from the study of inhibition of the CXCL12/CXCR4 activation axis for the melanoma cells. To mitigate the effects of the variability of the data on the cell viability measurement, the cell viability is theoretically constructed as a function of time depending on several parameters. The values of these parameters are estimated by using the experimental data. Deriving approximation for the cell viability in a theoretically pre-determined form has the advantages of (i) being less sensitive to data variability (ii) the estimated values of the parameters are interpreted directly in the biological processes, (iii) the amount of variability explained via the approximation validates the quality of the model, (iv) with the data integrated into the model one can derive a more complete view over the whole process. These advantages are demonstrated in the step-by-step implementation of the outlined approach.

q-bio.QM